RxDoctor Payments Data

Brenda Proctor

Family · Opelousas, LANPI 1790169928

Payments from drug & device makers

$727in general payments, 2019–2025

Across 17 payments — averaging $42.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Hollister Incorporated$168
  • Organogenesis Inc.$162
  • Paratek Pharmaceuticals, Inc.$153
  • Boehringer Ingelheim$110
  • KCI USA, Inc.$58
  • AbbVie$34
  • plus $41 from 2 others

What the payments were for

  • Food & beverage$727100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Hollister Incorporated4$168
Organogenesis Inc.2$162
Paratek Pharmaceuticals, Inc.3$153
Boehringer Ingelheim1$110
KCI USA, Inc.3$58
AbbVie2$34
Boston Scientific1$27
Biowound Solutions, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$727 in reported general payments places this provider in the 55th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana

Medicare billing

Part B allowed, 2024
$11,536
Medicare patients
74
Services billed
303

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate39$1,027
Doxycycline Hyclate22$326
Fluticasone Propionate16$200
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$125

Paid to pharmacies, not to this prescriber.

Other family in Opelousas

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →